Montela chewable tablet 5 mg (Montelukast Sodium)
Montelukast Sodium 5.2mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.
MFDS item code 202000806 · Approved 2020.02.11
This product's status changed to Approval withdrawn on 2024.07.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication helps to prevent asthma attacks and provides ongoing treatment. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.
This drug is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the dosing time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 packet, or 1 sheet once daily in the evening. Adults and adolescents aged 15 years and older: Administer montelukast 10 mg orally once daily. Adults and adolescents aged 15 years and older: Place montelukast 10 mg on the tongue once daily and allow it to dissolve; take without water. Administer this drug 1 hour before or 2 hours after a meal. To take this drug, pour the contents of 1 packet into a cup, add 10 mL of water, stir well, and take. Do not open the package until immediately before use; after opening, suspend in water and take the entire amount immediately (within 15 minutes). Do not leave this drug suspended in water for a long time. This 4 mg granule formulation may be taken directly by mouth or mixed with a small amount (about 5 mL) of soft food at or below room temperature, such as infant food, breast milk, or porridge. Do not open the package until immediately before use; after opening, mix with infant food, breast milk, or food, or take the entire amount as is, immediately (within 15 minutes). Do not leave this drug mixed with infant food, breast milk, or food for a long time; discard any remainder. This formulation is not designed to be mixed with beverages other than infant food or breast milk, but it is acceptable to drink a beverage immediately after taking it. This drug may be taken without regard to meals.
Children aged 6~14 years: Chew and take montelukast 5 mg once daily. Children aged 2~5 years: Chew and take montelukast 4 mg once daily. Children aged 6~14 years: Place montelukast 5 mg on the tongue once daily and, when it disintegrates, take without water. Children aged 2~5 years: Place montelukast 4 mg on the tongue once daily and, when it disintegrates, take without water. Children aged 6~14 years: Place montelukast 5 mg on the tongue once daily, allow it to dissolve, and take without water. Children aged 2~5 years: Place montelukast 4 mg on the tongue once daily, allow it to dissolve, and take without water. Children aged 6~14 years: Administer montelukast 5mg orally once daily. Asthma, children aged 2~5 years: Administer montelukast 4 mg orally once daily. Asthma, infants aged 12 months to under 2 years: Administer 4 mg of this drug orally once daily in the evening. Efficacy and safety for asthma have not been established in infants younger than 12 months. Allergic rhinitis, children aged 2~5 years: Administer montelukast 4 mg orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants younger than 2 years. Allergic rhinitis, infants aged 6 months to under 2 years: Administer 4mg of this drug orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants younger than 6 months. Administer this drug 1 hour before or 2 hours after a meal.
This medicine contains the artificial sweetener aspartame and should not be used in patients with phenylketonuria, who have problems in metabolizing phenylalanine. Daily intake of aspartame should be monitored to not exceed WHO recommendations, with a maximum of 2.4 grams per day for adults. Patients with allergies to this drug or its ingredients, as well as those with genetic metabolic disorders such as lactose intolerance or galactose intolerance, should not use this medication. When using this medication in asthmatic patients, side effects such as systemic weakness, fatigue, abdominal pain, headache, cough, rash, etc., may occur, so symptoms should be carefully monitored. Various adverse reactions such as pharyngitis, fever, diarrhea, headache, and ear infections have also been reported in pediatric patients, therefore, the condition of children should be closely observed. This drug is not to be used for acute asthma attacks; during acute exacerbations, emergency inhalers should always be at hand. Inhaled or oral corticosteroid preparations should not be abruptly discontinued; they should be gradually adjusted as directed by a physician. Patients who are hypersensitive to aspirin or non-steroidal anti-inflammatory drugs should not use these medications concurrently while taking this drug due to the risk of asthma exacerbation. Rarely, severe symptoms such as vasculitis and eosinophilia may occur while taking this medication, so if skin rash or worsening respiratory symptoms appear, consult a physician immediately. While no specific interactions have been reported with other medications, caution is advised as drug concentration variability may occur when used with some liver enzyme inducers. Women who are pregnant or breastfeeding should consult a physician before taking this medication and should only take it with great caution if necessary. It is possible to use this drug in children and the elderly, but attention should be paid to the potential differences in drug response related to age. In case of overdose, there is no specific antidote, requiring supportive symptomatic treatment and clinical monitoring as needed. This drug is sensitive to light; do not open the package until just before taking and consume it soon after opening. Store in a place out of reach of children and do not transfer to another container for safety. This drug should be taken regularly even when asthma symptoms are not present; consult a physician immediately if symptoms worsen or abnormal symptoms appear. For exercise-induced asthma patients, it is recommended not to rely solely on this drug for prevention, but to use it with inhaled bronchodilators.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to moisture and light, so it should be stored at room temperature between 1 degree and 30 degrees Celsius. It is also important to store it in a tightly sealed container to prevent air ingress.
Pink chewable tablet with a double convex round shape
28 tablets (7 tablets/PTP x 4), 30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 5.2mg
Tablet · Prescription medication
NBK Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.